Skip to Content, Navigation, or Footer.
The Tufts Daily
Where you read it first | Monday, April 15, 2024

Emilia Nathan


Bite-Size Science: FDA approves over-the-counter Narcan, an antidote for opioid overdose

The U.S. Food and Drug Administration approved Narcan for over-the-counter sale on March 29. Narcan, which is also known by its generic name, naloxone, is a fast-acting nasal spray medication produced by Emergent BioSolutions that reverses opioid overdoses. The decision comes two weeks after the Nonprescription Drugs Advisory Committee and Anesthetic and Analgesic Drug Products Advisory Committee unanimously voted in favor of allowing the nasal spray to be sold over the counter.

More articles »